Fermented Soybean Peptides That Taste Savory Also Lower Blood Pressure by Inhibiting ACE
Researchers identified peptides from fermented soybean curds that serve double duty — providing umami flavor and inhibiting ACE (a blood pressure enzyme) — with the peptide WEEF showing the best activity at an IC50 of 85 μM.
Quick Facts
What This Study Found
From fermented soybean curds, 11 candidate peptides with potential dual umami and ACE inhibitory activities were identified via nano-HPLC-MS/MS and database screening. Pharmacophore modeling confirmed high ACE inhibition probability (fit values >2) with binding through hydrogen bonds, electrostatic, and hydrophobic interactions.
Three synthesized peptides showed the following ACE inhibitory IC50 values: WEEF (85 ± 2 μM), FEF (170 ± 10 μM), and VE (205 ± 5 μM). Umami thresholds were WEEF (0.32 mM) < FEF (0.53 mM) < VE (4.8 mM). WEEF exhibited the best overall dual activity. Nitric oxide (NO) and endothelin-1 (ET-1) production were dose-dependent, further supporting vascular activity.
Key Numbers
How They Did This
Peptides were identified from fermented soybean curds using nano-HPLC-MS/MS. Candidates were screened for umami and ACE inhibitory potential using bioinformatics databases. Pharmacophore model analysis, molecular docking, and interaction energy calculations were performed. Three top candidates (VE, FEF, WEEF) were chemically synthesized and tested for ACE inhibitory activity (IC50), umami taste thresholds, and effects on NO and ET-1 production.
Why This Research Matters
The food industry is seeking natural ingredients that combine health benefits with desirable flavors. Peptides that simultaneously enhance taste (umami) and lower blood pressure (ACE inhibition) represent a particularly valuable class of functional food ingredients. Fermented soybean products are already widely consumed, making these peptides immediately relevant for developing 'functional foods' that taste good while providing cardiovascular benefits — without needing pharmaceutical drugs.
The Bigger Picture
This study sits at the intersection of food science and cardiovascular health, illustrating how traditional fermented foods contain bioactive peptides with genuine physiological effects. The screening methodology — combining mass spectrometry with computational pharmacophore modeling — provides an efficient pipeline for discovering dual-function peptides in food sources. As consumer demand grows for functional foods that provide health benefits beyond basic nutrition, food-derived bioactive peptides like these represent a promising bridge between nutrition and medicine.
What This Study Doesn't Tell Us
ACE inhibition was demonstrated in vitro and through computational modeling, not in animal or human studies. The IC50 values (85-205 μM) are moderate compared to pharmaceutical ACE inhibitors. Whether these peptides survive gastrointestinal digestion to reach systemic circulation is unknown. The umami taste evaluation methodology and panel details are not described in the abstract. NO and ET-1 effects were measured in cell-based assays, not in vivo blood pressure studies.
Questions This Raises
- ?Do these soybean peptides survive digestion and reach the bloodstream in concentrations sufficient for ACE inhibition?
- ?Could fermented soybean products be reformulated to concentrate these dual-function peptides for enhanced cardiovascular benefits?
- ?How do these peptides compare in ACE inhibitory potency to other food-derived antihypertensive peptides from dairy or fish sources?
Trust & Context
- Key Stat:
- IC50 = 85 μM ACE inhibitory potency of the peptide WEEF from fermented soybean curds — the most potent of three dual umami-ACE inhibitory peptides identified
- Evidence Grade:
- This is a preclinical food science study combining analytical chemistry, computational modeling, and in vitro bioactivity testing. The evidence is strong for the existence and dual activity of these peptides, but no animal or human studies validate actual blood pressure effects.
- Study Age:
- Published in 2025, this study reflects the growing interest in characterizing bioactive peptides in traditional fermented foods using modern analytical and computational techniques.
- Original Title:
- Identification and characterization of umami-ACE inhibitory peptides from traditional fermented soybean curds.
- Published In:
- Food chemistry, 465(Pt 2), 142160 (2025)
- Authors:
- Wei, Guanmian, Zhao, Feiran, Zhang, Ziyi, Regenstein, Joe M, Sang, Yaxin, Zhou, Peng
- Database ID:
- RPEP-14106
Evidence Hierarchy
Frequently Asked Questions
Can eating fermented soybean products lower blood pressure?
This study found that peptides in fermented soybean curds can inhibit ACE (a key blood pressure enzyme) in lab tests. However, whether eating these products provides enough peptide to affect blood pressure in humans hasn't been tested. The peptides would need to survive digestion and reach the bloodstream in sufficient amounts.
What makes a peptide taste umami?
Umami (savory) taste is triggered when molecules bind to specific taste receptors on the tongue. Certain short peptides produced during soybean fermentation can activate these receptors. This study found that the same molecular features that create umami taste (hydrogen bonds and specific amino acid interactions) also allow these peptides to bind to ACE — creating a natural dual function.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14106APA
Wei, Guanmian; Zhao, Feiran; Zhang, Ziyi; Regenstein, Joe M; Sang, Yaxin; Zhou, Peng. (2025). Identification and characterization of umami-ACE inhibitory peptides from traditional fermented soybean curds.. Food chemistry, 465(Pt 2), 142160. https://doi.org/10.1016/j.foodchem.2024.142160
MLA
Wei, Guanmian, et al. "Identification and characterization of umami-ACE inhibitory peptides from traditional fermented soybean curds.." Food chemistry, 2025. https://doi.org/10.1016/j.foodchem.2024.142160
RethinkPeptides
RethinkPeptides Research Database. "Identification and characterization of umami-ACE inhibitory ..." RPEP-14106. Retrieved from https://rethinkpeptides.com/research/wei-2025-identification-and-characterization-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.